Romejko Katarzyna, Szamotulska Katarzyna, Rymarz Aleksandra, Tomasz Rozmyslowicz, Niemczyk Stanisław
Department of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine-National Research Institute, Warsaw, Poland.
Department of Epidemiology and Biostatistics, Institute of Mother and Child, Warsaw, Poland.
Front Med (Lausanne). 2024 Jul 25;11:1380026. doi: 10.3389/fmed.2024.1380026. eCollection 2024.
Muscle atrophy affects more than 50% of patients with chronic kidney disease (CKD) and is associated with increased morbidity and mortality. It is crucial to understand the mechanisms involved in the muscle atrophy in CKD and search for specific determinants of skeletal muscle mass loss, especially those which are available in everyday medical practice. This study aimed to evaluate the association between appendicular skeletal muscle mass (ASM) and anthropometric, body composition, nutritional, inflammatory, metabolic, and kidney function variables in non-dialysis-dependent CKD men.
A total of 85 men with CKD and eGFR lower than 60 mL/min/1.73 m were included in the cross-sectional study: 24 participants with eGFR 59-45 mL/min/1.73 m, 32 individuals with eGFR 44-30 mL/min/1.73 m, and 29 men with eGFR ≤29 mL/min/1.73 m. ASM was estimated by bioimpedance spectroscopy (BIS) with the use of a Body Composition Monitor (BCM). To evaluate ASM from BCM, Lin's algorithm was used. Among anthropometric parameters, height, weight, and body mass index (BMI) were measured. Serum laboratory measurements were grouped into kidney function, nutritional, inflammatory, and metabolic parameters.
ASM was significantly associated with anthropometric and body composition variables. According to the anthropometric parameters, ASM correlated positively with weight, height, and BMI ( < 0.001 and = 0.913, < 0.001 and = 0.560, and < 0.001 and = 0.737, respectively). Among body composition variables, ASM correlated significantly and positively with lean tissue mass (LTM) ( < 0.001, = 0.746), lean tissue index (LTI) ( < 0.001, = 0.609), fat mass ( < 0.001, = 0.489), and fat tissue index (FTI) ( < 0.001, = 0.358). No other statistically significant correlation was found between ASM and kidney, nutritional, metabolic, and inflammatory variables.
In male patients with CKD stages G3-G5 not treated with dialysis, ASM correlates significantly and positively with anthropometric and body composition parameters such as weight, height, BMI, LTM, LTI, fat mass, and FTI. We did not observe such relationship between ASM and kidney function, nutritional, metabolic, and inflammatory variables.
肌肉萎缩影响超过50%的慢性肾脏病(CKD)患者,并与发病率和死亡率增加相关。了解CKD患者肌肉萎缩的相关机制并寻找骨骼肌质量损失的特定决定因素至关重要,尤其是那些在日常医疗实践中可用的因素。本研究旨在评估非透析依赖的CKD男性患者的四肢骨骼肌质量(ASM)与人体测量学、身体成分、营养、炎症、代谢及肾功能变量之间的关联。
共有85例估算肾小球滤过率(eGFR)低于60 mL/min/1.73 m²的CKD男性患者纳入本横断面研究:24例eGFR为59 - 45 mL/min/1.73 m²,32例eGFR为44 - 30 mL/min/1.73 m²,29例eGFR≤29 mL/min/1.73 m²。使用人体成分监测仪(BCM)通过生物电阻抗光谱法(BIS)估算ASM。为从BCM评估ASM,采用了林氏算法。在人体测量参数中,测量身高、体重和体重指数(BMI)。血清实验室检测指标分为肾功能、营养、炎症和代谢参数。
ASM与人体测量学和身体成分变量显著相关。根据人体测量参数,ASM与体重、身高和BMI呈正相关(分别为P < 0.001,r = 0.913;P < 0.001,r = 0.560;P < 0.001,r = 0.737)。在身体成分变量中,ASM与瘦组织质量(LTM)(P < 0.001,r = 0.746)、瘦组织指数(LTI)(P < 0.001,r = 0.609)、脂肪量(P < 0.001,r = 0.489)和脂肪组织指数(FTI)(P < 0.001,r = 0.358)显著正相关。未发现ASM与肾脏、营养、代谢和炎症变量之间存在其他具有统计学意义的相关性。
在未接受透析治疗的G3 - G5期CKD男性患者中,ASM与人体测量学和身体成分参数如体重、身高、BMI、LTM、LTI、脂肪量和FTI显著正相关。我们未观察到ASM与肾功能、营养、代谢和炎症变量之间存在此类关系。